Selskabets formål er at drive virksomhed med udvikling af lægemidler og hermed forbundet virksomhed.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | - | - | 13.8 mio. | 5.9 mio. | 7 | |
CVR: 38778676
Previous names: SYNKLINO IVS, SYNKLINO ApS
Compared to 1.002 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
STRATEGIC INVESTMENTS A/S registered with 10% ownership
MARIE RUDKJÆR SCHRØDER ApS registered with 5% ownership
Winther Schrøder Holding ApS registered with 5% ownership
Herwig-Ulf Johannes Richard Meier-Kriesche joined the board
Companies in the same industry and area
companydata.dk